Flagship Harbor Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Flagship Harbor Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-325	Closed	–	–	2251
2020 Q2	$0	Sell	325 -140	-30%	-$265	﹤0.01%	2219
2020 Q1	$1K	Hold	465	–	–	﹤0.01%	1849
2019 Q4	$1K	Sell	465 -630	-58%	-$2.02K	﹤0.01%	1862
2019 Q3	$5K	Hold	1,095	–	–	﹤0.01%	1525
2019 Q2	$10K	Sell	1,095 -350	-24%	-$6.44K	﹤0.01%	1317
2019 Q1	$38K	Sell	1,445 -125	-8%	-$3.18K	0.01%	840
2018 Q4	$35K	Hold	1,570	–	–	0.01%	819
2018 Q3	$84K	Buy	1,570 +100	+7%	+$6.38K	0.02%	647
2018 Q2	$104K	Buy	+1,470	New	+$104K	0.02%	571

Flagship Harbor Advisors's TTPH Position: Q3 2020 in Review

Flagship Harbor Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 325 shares.

Flagship Harbor Advisors first reported a position in TTPH in Q2 2018 and held it in 9 quarters. The position peaked at $104K in Q2 2018. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

Flagship Harbor Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 325 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020.
Flagship Harbor Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2018 and held it in 9 quarters.
Flagship Harbor Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $104K in Q2 2018.
1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on Flagship Harbor Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.